Transplantation companies specialize in the field of organ and tissue transplantation. These companies contribute to transplantation medicine by providing organ preservation solutions, immunosuppressive medications, and technologies aimed at improving the success rates and outcomes of organ and tissue transplants.
Latest Transplantation Companies Update
TransMedics expands their OCS program groundbreaking Organ Care System for hearts now sees wider adoption in the US, potentially increasing access to life-saving heart transplants.
United Therapeutics and Lung Therapeutics Partner collaboration focuses on developing ex vivo lung perfusion technology, aiming to improve the viability of marginal lungs for transplantation.
Cellome AI introduces a machine learning algorithm for kidney matching technology helps optimize donor-recipient matching, potentially reducing wait times and improving transplant outcomes.
Organogenesis expands its portfolio acquisition of MiMedX strengthens their regenerative medicine offerings, potentially impacting their tissue and cellular products used in transplant procedures.
Thermo Fisher Scientific partners with Rencare Therapeutics collaboration focuses on developing next-generation immunosuppressive drugs to prevent organ rejection following transplantation.
Lonza enters a strategic partnership with CING Therapeutics joint efforts aim to develop and manufacture cell therapies for various medical applications, including potential use in transplantation medicine.List of Transplantation Key Companies in the Market
Transplantation Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)